

Texas Oncology is a leader in groundbreaking cancer research and clinical trials in Texas, paving the way for new breakthroughs in cancer care.
Texas Oncology specialists are equipped to diagnose myelodysplastic syndrome and may use the following tests:
Physical exams allow physicians to detect potential MDS signs and symptoms early like fatigue and shortness of breath.
CBC measures the number of red blood cells, white blood cells, and platelets. It can reveal abnormally low blood cell count and other changes that may be indicative of MDS.
This medical procedure involves extracting and examining a small sample of both liquid and bone marrow from the hip bone using a needle. The collected cell samples are examined under a microscope to assess the number, size, and maturity of blood cells and bone marrow structure.
This technique allows scientists to look at the DNA inside our cells. They mark the DNA with a special dye, so they can be seen under a microscope.
This method uses antibodies, which are tiny detectives that search for invaders, to find specific proteins (antigens) in cells. These proteins help doctors distinguish between myelodysplastic syndromes, leukemia, and other health conditions.
This technique helps identify different types of cells by looking for unique markers on the surface of the cells. It is like checking the ID badges of cells to see what they are.
This process looks at how many cells are in a sample and checks things like their size, shape, and whether they have any signs of tumors on their surface.
MDS treatment looks different for each person. That is why we personalize your treatment plan based on factors like age, medical history, general health, and treatment goals. Treatment for MDS may involve the following:
Medications like azacitidine or decitabine may be prescribed to slow the progression of the disease and improve blood counts. They work by targeting abnormal cells in the bone marrow.
This treatment involves replacing diseased blood-forming cells with healthy stem cells from a donor.
Blood and platelet transfusions are common supportive care measures for MDS patients. These transfusions help manage symptoms associated with anemia and low platelet count, such as fatigue and bleeding. Other supportive care measures may include antibiotics and iron chelation therapy.
Clinical trials for MDS patients may be available. Consult with your provider to learn more.
Personalized attention
With our care team, you receive an individualized evaluation and care plan. We are with you and your loved ones at every step, from diagnosis to treatment and beyond.
Experts close to home
We make it as easy as possible to access the care you need. With locations across the state, you are likely to find a provider near where you live and work.
In myelodysplastic syndrome (MDS), the bone marrow produces immature cells that do not fully develop into mature blood cells. As a result, a patient with MDS will have fewer mature blood cells, and the cells produced may not function properly. At Texas Oncology, we are here to provide trusted expertise, advanced treatments, and individualized care to help you navigate MDS.
What sets Texas Oncology apart is our collaborative, patient-centered approach. We offer access to a variety of treatments — from stem cell transplants to drug therapies. With more than 550 physicians across the state, our patients receive world-class care close to home.
When you seek care with us, you can expect a personalized care plan, a dedicated team alongside you, and the latest advancements in cancer treatment, all designed to support you.
Myelodysplastic syndrome (MDS) is a group of diseases where the bone marrow does not make enough healthy blood cells. In 2022, doctors updated how they classify MDS to better understand and treat it. Now, they look at other factors like how many immature cells (called blasts) are in the blood and bone marrow, and whether certain gene changes are present. Here are the main types:
The cause of MDS in unknown, but MDS has been linked to several known risk factors:
Patients with MDS may not display any signs or symptoms. Instead, MDS is usually detected through an abnormal blood test with a low blood cell count. If you notice that any of the MDS symptoms keep coming back or worsen over time, talk with your doctor as soon as possible. That way, you can rule out whether your symptoms are caused by MDS or other conditions. Some symptoms include:
Texas Oncology specialists are equipped to diagnose myelodysplastic syndrome and may use the following tests:
Physical exams allow physicians to detect potential MDS signs and symptoms early like fatigue and shortness of breath.
CBC measures the number of red blood cells, white blood cells, and platelets. It can reveal abnormally low blood cell count and other changes that may be indicative of MDS.
This medical procedure involves extracting and examining a small sample of both liquid and bone marrow from the hip bone using a needle. The collected cell samples are examined under a microscope to assess the number, size, and maturity of blood cells and bone marrow structure.
This technique allows scientists to look at the DNA inside our cells. They mark the DNA with a special dye, so they can be seen under a microscope.
This method uses antibodies, which are tiny detectives that search for invaders, to find specific proteins (antigens) in cells. These proteins help doctors distinguish between myelodysplastic syndromes, leukemia, and other health conditions.
This technique helps identify different types of cells by looking for unique markers on the surface of the cells. It is like checking the ID badges of cells to see what they are.
This process looks at how many cells are in a sample and checks things like their size, shape, and whether they have any signs of tumors on their surface.
MDS treatment looks different for each person. That is why we personalize your treatment plan based on factors like age, medical history, general health, and treatment goals. Treatment for MDS may involve the following:
Medications like azacitidine or decitabine may be prescribed to slow the progression of the disease and improve blood counts. They work by targeting abnormal cells in the bone marrow.
This treatment involves replacing diseased blood-forming cells with healthy stem cells from a donor.
Blood and platelet transfusions are common supportive care measures for MDS patients. These transfusions help manage symptoms associated with anemia and low platelet count, such as fatigue and bleeding. Other supportive care measures may include antibiotics and iron chelation therapy.
Clinical trials for MDS patients may be available. Consult with your provider to learn more.
Specialized expertise
Our hematologists and medical oncologists bring their skills and extensive knowledge of blood diseases and disorders to each case.
Personalized attention
With our care team, you receive an individualized evaluation and care plan. We are with you and your loved ones at every step, from diagnosis to treatment and beyond.
Experts close to home
We make it as easy as possible to access the care you need. With locations across the state, you are likely to find a provider near where you live and work.